September 25

Antivirals: Targeting HBV and Beyond

Targeting Autophagy

September 26-27

Small Molecules for Cancer Immunotherapy

NK Cell-Based Cancer Immunotherapy

September 27-28

Autoimmune and Inflammation Drug Targets

Targeting Tumor Myeloid Cells

September 26-27

Targeting the Ubiquitin-Proteasome System

CNS and Neurodegenerative Targets

Constrained Peptides and Macrocyclics

Target Identification & Validation – Part 1

September 27-28

Kinase Inhibitor Discovery

GPCR-Based Drug Discovery

Lead Generation Strategies

Target Identification & Validation – Part 2

September 26-27

NASH and Fibrosis

September 27-28

Targeting the Microbiome

September 26-27

Antibody Discovery Forum – Part 1

Antibodies Against Membrane Protein Targets – Part 1

September 27-28

Antibody Discovery Forum – Part 2

Antibodies Against Membrane Protein Targets – Part 2

September 27-28

Introduction to Small Molecule Drug Discovery and Development

Part of Re-Entering Antibacterial Discovery and Development Summit

September 26-27

Antibacterial Discovery and Development

September 27-28

Targeting Gram Negative Pathogens

About the Event

The 16^th Annual Discovery on Target, “The Industry’s Preeminent Event on Novel Drug Targets,” will once again gather over 1,300 drug discovery professionals in Boston, MA, this September 25-28, 2018. The event brings forth current and emerging “hot” targets, technologies and validation strategies for the development of novel small molecules and biologics.